TSS
TPST icon

Two Sigma Securities’s Tempest Therapeutics TPST Stock Holding History

Two Sigma Securities’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,729
Closed -$156K – 3654
2023
Q4 		$156K Buy
2,729
+1,076
+65% +$50.9K ﹤0.01% 2459
2023
Q3 		$6.55K Buy
1,653
+533
+48% +$5.12K ﹤0.01% 2760
2023
Q2 		$18.5K Buy
+1,120
New +$28.2K ﹤0.01% 2522
2018
Q1 		– Sell
-12
Closed -$48K – 2956
2017
Q4 		$48K Buy
+12
New +$50.4K ﹤0.01% 1535
2017
Q2 		– Sell
-3
Closed -$19K – 1182
2017
Q1 		$19K Hold
3
– – ﹤0.01% 846
2016
Q4 		$16K Buy
+3
New +$37.4K 0.01% 665

Other funds holding TPST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Securities's TPST Position: Q1 2024 in Review

Two Sigma Securities sold out of Tempest Therapeutics (TPST) in Q1 2024, closing a stake of 2,729 shares — an estimated $156K sold.

Two Sigma Securities first reported a position in TPST in Q4 2016 and held it in 6 quarters. The position peaked at $156K in Q4 2023. 28 funds tracked by Wall St. Rank hold TPST as of Q1 2024.

  • Two Sigma Securities reported no remaining Tempest Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Securities sold 2,729 Tempest Therapeutics shares in Q1 2024, an estimated $156K.
  • Two Sigma Securities first reported a position in Tempest Therapeutics in Q4 2016 and held it in 6 quarters.
  • Two Sigma Securities's Tempest Therapeutics position peaked at $156K in Q4 2023.
  • 28 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q1 2024.

Based on Two Sigma Securities's 13F filing for Q1 2024, filed 15 May 2024.